Equities research analysts forecast that Oracle Co. (NYSE:ORCL) will announce earnings per share (EPS) of $0.94 for the current fiscal quarter, according to Zacks Investment Research. Ten analysts have provided estimates for Oracle’s earnings. The lowest EPS estimate is $0.90 and the highest is $0.96. Oracle posted earnings of $0.89 per share in the same quarter last year, which would suggest a positive year over year growth rate of 5.6%. The firm is expected to report its next earnings report on Wednesday, June 20th.
According to Zacks, analysts expect that Oracle will report full-year earnings of $3.06 per share for the current year, with EPS estimates ranging from $2.90 to $3.11. For the next financial year, analysts forecast that the firm will report earnings of $3.30 per share, with EPS estimates ranging from $3.10 to $3.49. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that cover Oracle.
Oracle (NYSE:ORCL) last posted its quarterly earnings data on Monday, March 19th. The enterprise software provider reported $0.83 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.11. The company had revenue of $9.78 billion for the quarter, compared to analysts’ expectations of $9.77 billion. Oracle had a net margin of 9.25% and a return on equity of 21.77%. Oracle’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.69 earnings per share.
ORCL has been the topic of several research analyst reports. Vetr upgraded shares of Oracle from a “hold” rating to a “buy” rating and set a $51.77 price objective on the stock in a research report on Monday, February 5th. ValuEngine upgraded shares of Oracle from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Instinet initiated coverage on shares of Oracle in a research report on Wednesday, January 24th. They issued a “buy” rating and a $51.12 price objective on the stock. Nomura initiated coverage on shares of Oracle in a research report on Tuesday, January 23rd. They issued a “buy” rating and a $64.00 price objective on the stock. Finally, Morgan Stanley restated a “buy” rating on shares of Oracle in a research report on Sunday, March 18th. One investment analyst has rated the stock with a sell rating, sixteen have issued a hold rating and twenty-three have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $56.30.
In other news, insider Thomas Kurian sold 979,402 shares of the firm’s stock in a transaction that occurred on Friday, May 4th. The shares were sold at an average price of $45.40, for a total value of $44,464,850.80. Following the transaction, the insider now owns 114,871 shares in the company, valued at $5,215,143.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Dorian Daley sold 125,000 shares of the firm’s stock in a transaction on Monday, March 26th. The stock was sold at an average price of $45.95, for a total value of $5,743,750.00. Following the completion of the sale, the executive vice president now directly owns 161,954 shares of the company’s stock, valued at approximately $7,441,786.30. The disclosure for this sale can be found here. Insiders sold 2,557,015 shares of company stock worth $117,480,315 in the last 90 days. Company insiders own 29.00% of the company’s stock.
A number of hedge funds have recently made changes to their positions in ORCL. Centaurus Financial Inc. purchased a new stake in Oracle in the first quarter worth $106,000. Rainier Group Investment Advisory LLC purchased a new stake in Oracle in the first quarter worth $106,000. Tarbox Family Office Inc. lifted its stake in Oracle by 71.1% in the fourth quarter. Tarbox Family Office Inc. now owns 2,322 shares of the enterprise software provider’s stock worth $110,000 after acquiring an additional 965 shares during the period. Wealthcare Advisory Partners LLC lifted its stake in Oracle by 81,200.0% in the third quarter. Wealthcare Advisory Partners LLC now owns 2,439 shares of the enterprise software provider’s stock worth $118,000 after acquiring an additional 2,436 shares during the period. Finally, Cerebellum GP LLC purchased a new stake in Oracle in the fourth quarter worth $126,000. 56.43% of the stock is owned by institutional investors.
Shares of Oracle traded down $0.81, hitting $46.40, during trading on Thursday, Marketbeat.com reports. The company had a trading volume of 1,193,745 shares, compared to its average volume of 11,628,329. The company has a current ratio of 4.33, a quick ratio of 4.30 and a debt-to-equity ratio of 1.16. The stock has a market cap of $191.75 billion, a price-to-earnings ratio of 18.67, a price-to-earnings-growth ratio of 1.71 and a beta of 1.15. Oracle has a 52 week low of $43.74 and a 52 week high of $53.48.
Oracle declared that its Board of Directors has initiated a stock repurchase program on Friday, February 2nd that permits the company to repurchase $12.00 billion in outstanding shares. This repurchase authorization permits the enterprise software provider to reacquire shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.
The company also recently announced a quarterly dividend, which was paid on Tuesday, May 1st. Stockholders of record on Tuesday, April 17th were issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, April 16th. Oracle’s dividend payout ratio is 30.52%.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports application, platform, and infrastructure technologies for information technology (IT) environments worldwide. It provides services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.